16 research outputs found

    External Auditor Dealing With Deep Cyber Security of Open Networks

    Get PDF
    We focus on how you can release major updates to that customer as much as possible, and we suggest a new model called Cloud Storage Audit with verifiable outsourcing for major updates. Within this model, major updates can be outsourced safely to authorized parties, so the important thing throughout the customer is that downloading the update is being saved very little. Moreover, the design gives us the ability to verify the validity of the encrypted secret keys issued by the OA. Specifically, we employ external auditors in current general audit designs; allow it to act as a delegated party in our position, and is also responsible for secure audits and major key updates to resist key detection. When the cloud downloads new files, the client should download the encrypted password only in OA. The licensed party maintains the encrypted secret key from the client for cloud storage audit and updates the encrypted status every time. The client downloads the encrypted password to the authorized authority and encrypts it exactly as it would like to upload new files to the cloud. In our design, only the agriculture authority should keep the encrypted form of the customer's secret key. In our design, only the agriculture authority should keep the encrypted form of the customer's secret key. We formalize the meaning and type of security in this form

    Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

    No full text

    Alirocumab and cardiovascular outcomes after acute coronary syndrome

    No full text
    BACKGROUN

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    No full text

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    No full text

    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

    No full text
    BACKGROUN

    Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial

    No full text

    Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

    No full text

    Alirocumab reduces total hospitalizations and increases days alive and out of hospital in the ODYSSEY OUTCOMES trial

    No full text

    Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    No full text
    corecore